Regaining compliance with Nasdaq's listing requirements is a significant positive development for Jin Medical International. It removes the immediate risk of delisting, which can have a detrimental effect on stock price and investor confidence. This news is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term.